Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CPMV NASDAQ:LIFE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPMVMosaic ImmunoEngineering$0.67$0.66$0.30▼$1.05$4.88M-0.8450 shsN/ALIFEEthos Technologies Inc. Class A Common Stock$18.14-4.0%$19.02$9.45▼$32.50$1.14BN/A519,993 shs328,160 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPMVMosaic ImmunoEngineering0.00%0.00%+74.16%-9.53%+36.58%LIFEEthos Technologies Inc. Class A Common Stock-4.02%+18.87%-4.02%+1,813,999,900.00%+1,813,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPMVMosaic ImmunoEngineering$0.67$0.66$0.30▼$1.05$4.88M-0.8450 shsN/ALIFEEthos Technologies Inc. Class A Common Stock$18.14-4.0%$19.02$9.45▼$32.50$1.14BN/A519,993 shs328,160 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPMVMosaic ImmunoEngineering0.00%0.00%+74.16%-9.53%+36.58%LIFEEthos Technologies Inc. Class A Common Stock-4.02%+18.87%-4.02%+1,813,999,900.00%+1,813,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPMVMosaic ImmunoEngineering 0.00N/AN/AN/ALIFEEthos Technologies Inc. Class A Common Stock 2.33Hold$27.0048.84% UpsideCurrent Analyst Ratings BreakdownLatest LIFE and CPMV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/26/2026LIFEEthos Technologies Inc. Class A Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Sell (D)5/11/2026LIFEEthos Technologies Inc. Class A Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)5/8/2026LIFEEthos Technologies Inc. Class A Common Stock BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$20.00 ➝ $27.005/7/2026LIFEEthos Technologies Inc. Class A Common Stock Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$21.00 ➝ $27.004/22/2026LIFEEthos Technologies Inc. Class A Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageHold (C-)(Data available from 7/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPMVMosaic ImmunoEngineeringN/AN/AN/AN/A($1.03) per shareN/ALIFEEthos Technologies Inc. Class A Common Stock$485.82M2.35N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPMVMosaic ImmunoEngineering-$690K-$0.09N/AN/AN/AN/AN/A-1,908.81%N/ALIFEEthos Technologies Inc. Class A Common StockN/A-$3.15N/AN/AN/AN/AN/AN/AN/ALatest LIFE and CPMV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2026Q1 2026CPMVMosaic ImmunoEngineeringN/A-$0.02N/A-$0.02N/AN/A4/15/2026Q4 2025CPMVMosaic ImmunoEngineeringN/A-$0.03N/A-$0.03N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCPMVMosaic ImmunoEngineeringN/AN/AN/AN/AN/ALIFEEthos Technologies Inc. Class A Common StockN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPMVMosaic ImmunoEngineeringN/ALIFEEthos Technologies Inc. Class A Common Stock61.72%Insider OwnershipCompanyInsider OwnershipCPMVMosaic ImmunoEngineering80.99%LIFEEthos Technologies Inc. Class A Common Stock3.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPMVMosaic ImmunoEngineering37.24 million1.38 millionNot OptionableLIFEEthos Technologies Inc. Class A Common Stock61462.99 millionN/AN/ALIFE and CPMV HeadlinesRecent News About These CompaniesCopper One Announces Filing Of Amended And Restated Offering Document In Connection With Non-Brokered Listed Issuer Financing Exemption OfferingJune 19, 2026 | thenewswire.comTAmericore Announces LIFE Offering of up to $3,000,000June 15, 2026 | newsfilecorp.comN'LIFE-CHANGING': SpaceX's first employee opens up on HISTORIC IPO paydayJune 11, 2026 | youtube.comYThe Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common SharesJune 11, 2026 | newsfilecorp.comNSPARC AI Inc. Announces Closing of Final Tranche of Brokered LIFE Financing for $1.12 MillionJune 8, 2026 | globenewswire.comPrimary Hydrogen Announces LIFE OfferingJune 4, 2026 | newsfilecorp.comNGoldHaven Announces Upsized LIFE Offering to Advance Magno and Copeçal ProjectsJune 4, 2026 | globenewswire.comEthos Technologies Inc. (LIFE) Presents at 46th Annual William Blair Growth Stock Conference TranscriptJune 4, 2026 | seekingalpha.comCopper One Resources Corp. Announces Filing Of Amended And Restated Offering Document In Connection With Non-Brokered Listed Issuer Financing Exemption OfferingJune 4, 2026 | thenewswire.comTEthos Technologies Inc. (LIFE) Presents at 2026 Baird Global Consumer, Technology & Services Conference TranscriptJune 3, 2026 | seekingalpha.comEthos Technologies Inc. (LIFE) Presents at Bank of America 2026 Global Technology Conference TranscriptJune 2, 2026 | seekingalpha.comEthos Technologies Inc. Cl AMay 30, 2026 | wsj.comEthos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial EssentialMay 21, 2026 | globenewswire.comEthos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) CAO Sells $128,455.38 in StockMay 20, 2026 | insidertrades.comPyroGenesis Announces $3.0 Million Bought Deal LIFE Offering and Concurrent CEO Private Placement of up to $2.0 MillionMay 19, 2026 | newsfilecorp.comNStandard Uranium Announces Closing of LIFE OfferingMay 19, 2026 | newsfilecorp.comNInsider Selling: Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) Major Shareholder Sells 60,077 Shares of StockMay 19, 2026 | insidertrades.comEthos to Present at Upcoming Investor ConferencesMay 15, 2026 | globenewswire.comEthos Announces Early Lock-Up ReleaseMay 13, 2026 | globenewswire.comCopper One Resources Corp. Announces Non-Brokered LIFE Offering of up to $2,500,000May 12, 2026 | thenewswire.comTNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLIFE and CPMV Company DescriptionsMosaic ImmunoEngineering OTCMKTS:CPMV$0.67 0.00 (0.00%) As of 06/29/2026Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.Ethos Technologies Inc. Class A Common Stock NASDAQ:LIFE$18.14 -0.76 (-4.02%) As of 06/30/2026 04:00 PM EasternEthos Technologies Inc operates a technology-driven, direct-to-consumer platform for the distribution of life insurance products. Through its digital underwriting, data analytics, and proprietary technology, it enables consumers to explore, compare, and purchase life insurance policies online. The platform serves consumers, agents, and insurance carriers, and supports the application and policy issuance process through an online interface. The company works with insurance carriers to offer life insurance products in the United States through digital channels and independent agents. It generates revenue through commissions paid by carriers from policies activated and sold through its platform as well as from the provision of third-party administrator services for such policies. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas These 3 Dividend Stocks Could Boost Your Income This July The Quantum Bubble Is Real Enough to Take Seriously Amazon Could Be About to Reap the Rewards of a Software Spending Boom Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks Why Wall Street Still Sees Massive Upside for AeroVironment Stock AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed? Manchester United’s Stock Rally Faces a Test Beyond Old Trafford NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
